US Congress considers 'Netflix for antibiotics' funding model
By Nick Robertson ( August 20, 2026, 15:01 GMT | Comment) -- A bill to de-link antimicrobial innovation funding from volume and instead rely on fixed-rate funding for new drugs is gaining momentum in Washington, building off similar successful programs in the UK and Sweden to combat anti-microbial resistance and boost IP investments in the field.As fears of widespread antimicrobial resistance (AMR) rise, advocates are proposing increased government funding for antimicrobial drug research and commercialization under an innovation incentive model they say could spur the development and patenting of novel drugs without requiring increased sales. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.